Intracellular signaling and hepatocellular carcinoma.

Abstract:

:Liver cancer is the fifth most common cancer and the third most common cause of cancer related death in the world. The recent development of new techniques for the investigations of global change in the gene expression, signaling pathways and wide genome binding has provided novel information for the mechanisms underlying liver cancer progression. Although these studies identified gene expression signatures in hepatocellular carcinoma, the early steps of the development of hepatocellular carcinomas (HCC) are not well understood. The development of HCC is a multistep process which includes the progressive alterations of gene expression leading to the increased proliferation and to liver cancer. This review summarizes recent progress in the identification of the key steps of the development of HCC with the focus on early events of carcinogenesis and on the role of translational and epigenetic alterations in the development of HCC. Quiescent stage of the liver is supported by several tumor suppressor proteins including p53, Rb and C/EBPα. Studies with chemical models of liver carcinogenesis and with human HCC have shown that the elevation of gankyrin is responsible for the elimination of these three proteins at early steps of carcinogenesis. Later stages of progression of the liver cancer are associated with alterations in many signaling pathways including translation which leads to epigenetic silencing/activation of many genes. Particularly, recent reports suggest a critical role of histone deacetylase 1, HDAC1, in the development of HCC through the interactions with transcription factors such as C/EBP family proteins.

journal_name

Semin Cancer Biol

authors

Iakova P,Timchenko L,Timchenko NA

doi

10.1016/j.semcancer.2010.09.001

subject

Has Abstract

pub_date

2011-02-01 00:00:00

pages

28-34

issue

1

eissn

1044-579X

issn

1096-3650

pii

S1044-579X(10)00079-9

journal_volume

21

pub_type

杂志文章,评审
  • Metallothionein expression and transient resistance to electrophilic antineoplastic drugs.

    abstract::Intrinsic and acquired resistance to antineoplastic agents remains an important impediment to cancer therapy. Intracellular metallothioneins appear to be one factor in determining the responsiveness of malignant and normal cells to electrophilic anticancer agents. Metallothioneins are not only constitutively expressed...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Lazo JS,Basu A

    更新日期:1991-08-01 00:00:00

  • Tropomyosins as interpreters of the signalling environment to regulate the local cytoskeleton.

    abstract::A key regulator of cell morphology is the actin cytoskeleton and it has long been appreciated that the cytoskeleton is characteristically altered in cancer. Actin is organized into polymeric structures with distinct dynamics which in turn participate in a wide variety of cell processes including adhesion, migration, c...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2007.08.004

    authors: O'Neill GM,Stehn J,Gunning PW

    更新日期:2008-02-01 00:00:00

  • Cellular and viral ligands that interact with the EGF receptor.

    abstract::The growth regulatory functions of a family of structurally related polypeptides are mediated through the membrane-bound epidermal growth factor receptor molecule. This ligand family includes epidermal growth factor, transforming growth factor-alpha, amphiregulin, and polypeptides encoded by several poxviruses. The st...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Todaro GJ,Rose TM,Spooner CE,Shoyab M,Plowman GD

    更新日期:1990-08-01 00:00:00

  • Metastatic disease: a drug discovery perspective.

    abstract::Disseminated tumor cells are present in many patients at diagnosis. At a time when the disseminated disease becomes prominent, patients have already been treated with many cycles of therapy to which their metastases were also exposed. These metastases have genetically evolved from primary tumors. Furthermore, their in...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2012.03.005

    authors: Lehembre F,Regenass U

    更新日期:2012-06-01 00:00:00

  • Current and future systemic treatments for renal cell carcinoma.

    abstract::Systemic treatment of renal cell carcinoma has changed dramatically since 2007, with the development and approval of six new agents, which target complex molecular pathways regulating tumour angiogenesis and cell proliferation and survival. These treatments have significantly improved survival times in metastatic rena...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2012.06.004

    authors: Fisher R,Gore M,Larkin J

    更新日期:2013-02-01 00:00:00

  • Chemokines in neuroectodermal cancers: the crucial growth signal from the soil.

    abstract::Although chemokines and their receptors were initially identified as regulators of cell trafficking during inflammation and immune response, they have emerged as crucial players in all stages of tumor development, primary growth, migration, angiogenesis, and establishment as metastases in distant target organs. Neuroe...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2008.10.009

    authors: Gross N,Meier R

    更新日期:2009-04-01 00:00:00

  • Human papillomaviruses and skin cancer.

    abstract::Human papillomavirus (HPV)-induced skin warts are classically benign lesions. However an association between specific HPV types and skin cancer becomes obvious in epidermodysplasia verruciformis (EV). The analysis of this disease suggests that lesions infected with HPV types 5 and 8 carry a high risk of developing squ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Pfister H

    更新日期:1992-10-01 00:00:00

  • The role of Rel/NF-kappa B proteins in viral oncogenesis and the regulation of viral transcription.

    abstract::Rel/NF-kappa B is a ubiquitous transcription factor that consists of multiple polypeptide subunits, and is subject to complex regulatory mechanisms that involve protein-protein interactions, phosphorylation, ubiquitination, proteolytic degradation, and nucleocytoplasmic translocation. The sophisticated control of Rel/...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.1997.0063

    authors: Mosialos G

    更新日期:1997-04-01 00:00:00

  • The retinoblastoma protein and its relatives.

    abstract::The retinoblastoma tumor suppressor gene is inactivated in retinoblastomas and a variety of other tumor types. In addition, it is one of several cellular proteins targeted by the transforming proteins of the small DNA tumor viruses. At least two other cellular proteins that are targeted by the viral transforming prote...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.1995.0011

    authors: Whyte P

    更新日期:1995-04-01 00:00:00

  • Local delivery of poxvirus vaccines for melanoma.

    abstract::The development of vaccines for melanoma has been accelerated by the identification of melanoma-associated antigens, a better understanding of basic immunologic principles, and the ability to construct complex vectors for immunization. The location and context in which T-cell priming occurs significantly influences th...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2003.09.005

    authors: Hörig H,Kaufman HL

    更新日期:2003-12-01 00:00:00

  • The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?

    abstract::Neutrophils in the tumor host may promote tumor progression by enhancing angiogenesis, invasion and metastasis. Granulocytic myeloid-derived suppressor cells (MDSC) share many features with neutrophils. Classically, MDSC are viewed as and defined as immunosuppressive cells. In this article we summarize and critically ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2013.02.007

    authors: Brandau S,Moses K,Lang S

    更新日期:2013-06-01 00:00:00

  • A molecular genetic model of human bladder carcinogenesis.

    abstract::Human bladder carcinogenesis stands as a paradigm for research on the molecular genetic mechanisms of chemical carcinogenesis. The pathogenesis of bladder cancer is multistage with a typical onset later in life. Epidemiological studies associate occupational exposure to aromatic amines with increased bladder cancer ri...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Reznikoff CA,Kao C,Messing EM,Newton M,Swaminathan S

    更新日期:1993-06-01 00:00:00

  • Endogenous opiates, opioids, and immune function: evolutionary brokerage of defensive behaviors.

    abstract::Recent empirical data have elucidated a compelling physiological basis for endogenously expressed, chemically authentic, morphine and its cognate mu3 and mu4 opiate receptors. Cellular "morphinergic" signaling is predominantly targeted to autocrine/paracrine regulatory processes and is reciprocally linked to stimulate...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2007.12.001

    authors: Stefano GB,Kream R

    更新日期:2008-06-01 00:00:00

  • Harnessing serotonergic and dopaminergic pathways for lymphoma therapy: evidence and aspirations.

    abstract::Growing evidence supports the notion that pharmaceutical targeting of the 5-hydroxytryptamine (5-HT) and dopamine (DA) systems offers the potential to treat human immune system disorders. This review describes this emerging area of research, which has the benefit of being supported by a relatively detailed understandi...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2007.12.007

    authors: Barnes NM,Gordon J

    更新日期:2008-06-01 00:00:00

  • Bioblockades join the assault on small G protein signalling.

    abstract::Inhibition of Ras signalling has been a goal almost since its central role in cell signalling and its deregulation in disease were discovered. Early attempts at inhibiting its post-translational modification using peptidomimetics were successful in cell culture but failed spectacularly in clinical trials, making indus...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2018.01.001

    authors: Mott HR,Owen D

    更新日期:2019-02-01 00:00:00

  • The Raf-1 serine/threonine protein kinase.

    abstract::Raf-1 belongs to a family of serine/threonine protein kinases which are highly conserved through evolution in multicellular organisms. Raf-1 kinase has gained much attention due to its function as a critical shuttle enzyme that connects stimulation of growth factor receptors and protein kinase C at the cell membrane t...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Magnuson NS,Beck T,Vahidi H,Hahn H,Smola U,Rapp UR

    更新日期:1994-08-01 00:00:00

  • Genetic dissection of melanoma pathways in the mouse.

    abstract::The frequent loss of the INK4a/ARF locus, encoding for both p16(INK4a)and p19(ARF)in human melanoma, raises the question as to which INK4a/ARF gene product functions to suppress melanoma-genesis in vivo. Studies in the mouse have shown that activated RAS mutation can cooperate with INK4a(Delta 2/3)deficiency (null for...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2000.0376

    authors: Yang FC,Merlino G,Chin L

    更新日期:2001-06-01 00:00:00

  • APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis.

    abstract::The anaphase promoting complex/ cyclosome (APC/C), is an evolutionarily conserved protein complex essential for cellular division due to its role in regulating the mitotic transition from metaphase to anaphase. In this review, we highlight recent work that has shed light on our understanding of the role of APC/C coact...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2020.03.001

    authors: Schrock MS,Stromberg BR,Scarberry L,Summers MK

    更新日期:2020-12-01 00:00:00

  • The genomic risk of somatic gene therapy.

    abstract::Gene vectors with an untargeted insertion profile have been explored in preclinical models and clinical trials for the transfer of potentially therapeutic genetic information into somatic cells that have a high replicative potential. The gene-modified cell population can be viewed as a genetic mosaic whose complexity ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2010.06.003

    authors: Kustikova O,Brugman M,Baum C

    更新日期:2010-08-01 00:00:00

  • Tumour escape from immune surveillance through dendritic cell inactivation.

    abstract::Dendritic cells (DC) are central to the initiation of immunity. To induce immune reactivity, DC are recruited at the site of antigen expression, uptake antigens and migrate to secondary lymphoid organs while receiving activation signals delivered by pathogens, dying cells, and/or T cells. Tumours can escape the immune...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2001.0400

    authors: Vicari AP,Caux C,Trinchieri G

    更新日期:2002-02-01 00:00:00

  • Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer.

    abstract::Prostate cancer (PCa), a hormonally-driven cancer, ranks first in incidence and second in cancer related mortality in men in most Western industrialized countries. Androgen and androgen receptor (AR) are the dominant modulators of PCa growth. Over the last two decades multiple advancements in screening, treatment, sur...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2016.06.003

    authors: Kallifatidis G,Hoy JJ,Lokeshwar BL

    更新日期:2016-10-01 00:00:00

  • Repurposing drugs in oncology: From candidate selection to clinical adoption.

    abstract::Drug repurposing is a strategy that aims to develop novel cancer treatments through the reuse of existing medicines developed in other disease areas. Such a strategy includes the identification of candidate drugs, clinical development, drug licensing, reimbursement and clinical implementation. This review outlines a l...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2020.01.008

    authors: Pantziarka P,Verbaanderd C,Huys I,Bouche G,Meheus L

    更新日期:2020-01-23 00:00:00

  • NanoString in the screening of genetic abnormalities associated with thyroid cancer.

    abstract::In the setting of cancer pathology, molecular characterization of tumors providing diagnostic and predictive information is acquiring more and more relevance. Moreover, the advent of innovative technologies continuously improves the knowledge of the molecular landscape of tumors and strengthens the links between clini...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2020.10.004

    authors: Macerola E,Poma AM,Basolo F

    更新日期:2020-10-19 00:00:00

  • Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence.

    abstract::Data accumulating during the last two decades suggest that tumorigenesis is held in check by two major intrinsic failsafe mechanisms; apoptosis and cellular senescence. While apoptosis is a programmed cell death process, cellular senescence, which is the focus of this article, is defined as irreversible cell cycle arr...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2011.10.005

    authors: Larsson LG

    更新日期:2011-12-01 00:00:00

  • Aberrations in DNA repair pathways in cancer and therapeutic significances.

    abstract::Cancer cells show various types of mutations and aberrant expression in genes involved in DNA repair responses. These alterations induce genome instability and promote carcinogenesis steps and cancer progression processes. These defects in DNA repair have also been considered as suitable targets for cancer therapies. ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.02.005

    authors: Motegi A,Masutani M,Yoshioka KI,Bessho T

    更新日期:2019-10-01 00:00:00

  • Molecular mechanistic insights: The emerging role of SOXF transcription factors in tumorigenesis and development.

    abstract::Over the last decade, the development and progress of next-generation sequencers incorporated with classical biochemical analyses have drastically produced novel insights into transcription factors, including Sry-like high-mobility group box (SOX) factors. In addition to their primary functions in binding to and activ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.09.008

    authors: Higashijima Y,Kanki Y

    更新日期:2020-12-01 00:00:00

  • The weight of obesity in breast cancer progression and metastasis: Clinical and molecular perspectives.

    abstract::The escalating epidemic of overweight and obesity is currently recognized as one of the most significant health and economic concern worldwide. At the present time, over 1.9 billion adults and more than 600 million people can be, respectively, classified as overweight or obese, and numbers will continue to increase in...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.09.001

    authors: Barone I,Giordano C,Bonofiglio D,Andò S,Catalano S

    更新日期:2020-02-01 00:00:00

  • MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation.

    abstract::The discovery of microRNAs (miRNAs) is one of the major scientific breakthroughs in recent years and has revolutionized the way we look at gene regulation. Although we are still at a very early stage in understanding their impact on immunity, miRNAs are changing the way we think about the development of the immune sys...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2008.01.005

    authors: Sonkoly E,Ståhle M,Pivarcsi A

    更新日期:2008-04-01 00:00:00

  • Proteomic research in sarcomas - current status and future opportunities.

    abstract::Sarcomas are a rare group of mesenchymal cancers comprising over 70 different histological subtypes. For the majority of these diseases, the molecular understanding of the basis of their initiation and progression remains unclear. As such, limited clinical progress in prognosis or therapeutic regimens have been made o...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.11.003

    authors: Burns J,Wilding CP,L Jones R,H Huang P

    更新日期:2020-04-01 00:00:00

  • Novel therapeutic interventions in cancer treatment using protein and peptide-based targeted smart systems.

    abstract::Cancer, being the most prevalent and resistant disease afflicting any gender, age or social status, is the ultimate challenge for the scientific community. The new generation therapeutics for cancer management has shifted the approach to personalized/precision medicine, making use of patient- and tumor-specific marker...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.08.023

    authors: Zafar S,Beg S,Panda SK,Rahman M,Alharbi KS,Jain GK,Ahmad FJ

    更新日期:2019-08-20 00:00:00